|
1
|
Kakino M, Tazawa S, Maruyama H, et al:
Laxative effects of agarwood on low-fiber diet-induced constipation
in rats. BMC Complement Altern Med. 10:682010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jones R and Lydeard S: Irritable bowel
syndrome in the general population. BMJ. 304:87–90. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Talley NJ, Stanghellini V, Heading RC, et
al: Functional gastroduodenal disorders. Gut. 45:II37–II42. 1999.
View Article : Google Scholar
|
|
4
|
Mostafa SM, Bhandari S, Ritchie G, Gratton
N and Wenstone R: Constipation and its implications in the
critically ill patient. Br J Anaesth. 91:815–819. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rao SS and Go JT: Update on the management
of constipation in the elderly: new treatment options. Clin Interv
Aging. 5:163–171. 2010.PubMed/NCBI
|
|
6
|
Siegers CP, von Hertzberg-Lottin E, Otte M
and Schneider B: Anthranoid laxative abuse - a risk for colorectal
cancer. Gut. 34:1099–1101. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kojima R, Doihara H, Nozawa K, et al:
Characterization of two models of drug-induced constipation in mice
and evaluation of mustard oil in these models. Pharmacology.
84:227–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hughes S, Higgs NB and Turnberg LA:
Loperamide has antisecretory activity in the human jejunum in
vivo. Gut. 25:931–935. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sohji Y, Kawashima K and Shimizu M:
Pharmacological studies of loperamide, an anti-diarrheal agent. II.
Effects on peristalsis of the small intestine and colon in guinea
pigs (author’s transl). Nihon Yakurigaku Zasshi. 74:155–163.
1978.(In Japanese).
|
|
10
|
Yamada K and Onoda Y: Comparison of the
effects of T-1815, yohimbine and naloxone on mouse colonic
propulsion. J Smooth Muscle Res. 29:47–53. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Takasaki K, Kishibayashi N, Ishii A and
Karasawa A: Effects of KW-5092, a novel gastroprokinetic agent, on
the delayed colonic propulsion in rats. Jpn J Pharmacol. 65:67–71.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cho YE, Alcantara E, Kumaran S, et al: Red
yeast rice stimulates osteoblast proliferation and increases
alkaline phosphatase activity in MC3T3-E1 cells. Nutr Res.
30:501–510. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lu HE, Jian CH, Chen SF, et al:
Hypoglycaemic effects of fermented mycelium of Paecilomyces
farinosus (G30801) on high-fat fed rats with
streptozotocin-induced diabetes. Indian J Med Res. 131:696–701.
2010.PubMed/NCBI
|
|
14
|
Ho BY, Wu YM, Hsu YW, et al: Effects of
Monascus-fermented rice extract on malignant cell-associated
neovascularization and intravasation determined using the chicken
embryo chorioallantoic membrane model. Integr Cancer Ther.
9:204–212. 2010. View Article : Google Scholar
|
|
15
|
Lee CL, Kuo TF, Wu CL, Wang JJ and Pan TM:
Red mold rice promotes neuroprotective sAPPalpha secretion instead
of Alzheimer’s risk factors and amyloid beta expression in
hyperlipidemic Abeta40-infused rats. J Agric Food Chem.
58:2230–2238. 2010.PubMed/NCBI
|
|
16
|
Setnikar I, Senin P and Rovati LC:
Antiatherosclerotic efficacy of policosanol, red yeast rice extract
and astaxanthin in the rabbit. Arzneimittelforschung. 55:312–317.
2005.PubMed/NCBI
|
|
17
|
Kim KM, Yu KW, Kang DH and Suh HJ:
Anti-stress and anti-fatigue effect of fermented rice bran.
Phytother Res. 16:700–702. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee JK, Cho HR, Kim KY, et al: Lactic acid
bacteria and Bifidobacterium spp. growth stimulating effects
of fermented rice extract (FRe). Food Sci Technol Res. 20:479–483.
2014.
|
|
19
|
Forth W, Nell G, Rummel W and Andres H:
The hydragogue and laxative effect of the sulfuric acid ester and
the free diphenol of 4,4′-dihydroxydiphenyl-(pyridyl-2)-methane.
Naunyn Schmiedebergs Arch Pharmacol. 274:46–53. 1972.PubMed/NCBI
|
|
20
|
Jauch R, Hankwitz R, Beschke K and Pelzer
H: Bis-(p-hydroxyphenyl)-pyridyl-2-methane: the common laxative
principle of Bisacodyl and sodium picosulphate.
Arzneimittelforschung. 25:1796–1800. 1975.PubMed/NCBI
|
|
21
|
Méité S, Bahi C, Yéo D, et al: Laxative
activities of Mareya micrantha (Benth.) Müll Arg
(Euphorbiaceae) leaf aqueous extract in rats. BMC Complement Altern
Med. 10:72010.
|
|
22
|
Bustos D, Ogawa K, Pons S, et al: Effect
of loperamide and bisacodyl on intestinal transit time, fecal
weight and short chain fatty acid excretion in the rat. Acta
Gastroenterol Latinoam. 21:3–9. 1991.PubMed/NCBI
|
|
23
|
Wintola OA, Sunmonu TO and Afolayan AJ:
The effect of Aloe ferox Mill. in the treatment of
loperamide-induced constipation in Wistar rats. BMC Gastroenterol.
10:952010.
|
|
24
|
Sagar L, Sehgal R and Ojha S: Evaluation
of antimotility effect of Lantana camara L. var. acuelata
constituents on neostigmine induced gastrointestinal transit in
mice. BMC Complement Altern Med. 5:182005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wu D, Zhou J, Wang X, et al: Traditional
Chinese formula, lubricating gut pill, stimulates cAMP-dependent
Cl(−) secretion across rat distal colonic mucosa. J Ethnopharmacol.
134:406–413. 2011.PubMed/NCBI
|
|
26
|
Yang ZH, Yu HJ, Pan A, et al: Cellular
mechanisms underlying the laxative effect of flavonol naringenin on
rat constipation model. PLoS One. 3:e33482008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
McCullogh JS, Ratcliffe B, Mandir N, Carr
KE and Goodlad RA: Dietary fibre and intestinal microflora: effects
on intestinal morphometry and crypt branching. Gut. 42:799–806.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Isawa K, Hojo K, Yoda N, et al: Isolation
and identification of a new bifidogenic growth stimulator produced
by Propionibacterium freudenreichii ET-3. Biosci Biotechnol
Biochem. 66:679–681. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mäkeläinen H, Hasselwander O, Rautonen N
and Ouwehand AC: Panose, a new prebiotic candidate. Lett Appl
Microbiol. 49:666–672. 2009.
|
|
30
|
Hojo K, Yoda N, Tsuchita H, et al: Effect
of ingested culture of Propionibacterium freudenreichii ET-3
on fecal microflora and stool frequency in healthy females. Biosci
Microflora. 21:115–120. 2002.
|
|
31
|
Uchida M, Mogami O and Matsueda K:
Characteristic of milk whey culture with Propionibacterium
freudenreichii ET-3 and its application to the inflammatory
bowel disease therapy. Inflammopharmacology. 15:105–108.
2007.PubMed/NCBI
|
